MedPath

NALOXONE HYDROCHLORIDE INJECTION, USP

NALOXONE HYDROCHLORIDE INJECTION, USP

Approved
DIN Number

02534967

Drug Class

Human

Market Date

N/A

Company
HC

eugia pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02534967
AIG Number0108981002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AB15 NALOXONE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Subcutaneous ,  Intramuscular
AHFS Classification28:10.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NALOXONE HYDROCHLORIDEActive
Strength: 0.4 MG / ML
Monograph: NALOXONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.